Table 1

Distribution of the study variables in kidney transplant and liver transplant recipients with Acinetobacter baumannii infection
Variable Liver transplant (total = 25) Kidney transplant (total = 24) p
n (%) n(%)
Male sex 16 (64) 13 (54) 0.48
Agea 56 (38–63) 44 (31–55) 0.09
Infection acquired in the ICU 22 (88) 2 (8) <0.001
Previous use of any antibioticb 11 (55) 11 (55) 1.0
Previous use of carbapenem b 8 (40) 3 (15) 0.08
Non-urinary site of infection 24 (96) 11 (46) <0.001
 Primary bacteremia 9 (36) 8 (33)
 Pneumonia 11 (44) 2 (18)
 Surgical site infection 4 (16) 1 (4)
Bacteremia c 16 (64) 12 (50) 0.32
Central venous catheter 25 (100) 6 (25) <0.001
Mechanical ventilation 21 (84) 4 (17) <0.001
Serum creatinine (μmol/L ) a 130 (90 – 200) 320 (120–500) 0.009
Hemodialysis 8 (32) 4 (17) 0.21
Treated for acute graft rejection 1 (4) 11 (46) 0.001
Septic shock 11 (44) 4 (17) 0.04
Appropriate empiric therapy for A. baumannii infection 17 (68) 12 (50) 0.20
Resistance to carbapenem 12 (48) 6 (33) 0.10

ICU – intensive care unit; a median (interquartile range); b Data available in 40 patients; c includes 11 cases of secondary bacteremia.

de Gouvêa et al.

de Gouvêa et al. BMC Infectious Diseases 2012 12:351   doi:10.1186/1471-2334-12-351

Open Data